12-45851241-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_152641.4(ARID2):c.3118G>C(p.Val1040Leu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_152641.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARID2 | NM_152641.4 | c.3118G>C | p.Val1040Leu | missense_variant | 15/21 | ENST00000334344.11 | NP_689854.2 | |
ARID2 | NM_001347839.2 | c.3118G>C | p.Val1040Leu | missense_variant | 15/20 | NP_001334768.1 | ||
ARID2 | XM_047428489.1 | c.3118G>C | p.Val1040Leu | missense_variant | 15/17 | XP_047284445.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARID2 | ENST00000334344.11 | c.3118G>C | p.Val1040Leu | missense_variant | 15/21 | 1 | NM_152641.4 | ENSP00000335044 | P1 | |
ARID2 | ENST00000422737.7 | c.3118G>C | p.Val1040Leu | missense_variant | 15/20 | 1 | ENSP00000415650 | |||
ARID2 | ENST00000444670.5 | c.1966G>C | p.Val656Leu | missense_variant | 7/13 | 1 | ENSP00000397307 | |||
ARID2 | ENST00000479608.5 | c.*1668G>C | 3_prime_UTR_variant, NMD_transcript_variant | 9/15 | 1 | ENSP00000514783 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.